BlackRock Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$131M Sell
356,866
-245,615
-41% -$93.4M 0.14% 166
2016
Q3
$242M Buy
602,481
+183,538
+44% +$73.6M 0.26% 100
2016
Q2
$146M Buy
418,943
+227,998
+119% +$87.8M 0.16% 157
2016
Q1
$68.8M Sell
190,945
-71,521
-27% -$29.5M 0.07% 262
2015
Q4
$142M Buy
262,466
+20,224
+8% +$11M 0.16% 152
2015
Q3
$113M Sell
242,242
-17,697
-7% -$9.5M 0.13% 182
2015
Q2
$133M Sell
259,939
-172,728
-40% -$84.3M 0.14% 162
2015
Q1
$195M Sell
432,667
-120,098
-22% -$50.9M 0.21% 129
2014
Q4
$227M Sell
552,765
-205,344
-27% -$80.8M 0.24% 114
2014
Q3
$273M Sell
758,109
-177,228
-19% -$59.4M 0.28% 91
2014
Q2
$264M Buy
935,337
+356,403
+62% +$106M 0.26% 103
2014
Q1
$174M Sell
578,934
-104,139
-15% -$32.1M 0.17% 149
2013
Q4
$188M Buy
683,073
+44,159
+7% +$12.7M 0.18% 144
2013
Q3
$200M Buy
638,914
+311,756
+95% +$82M 0.2% 134
2013
Q2
$73.6M Buy
+327,158
New +$76.2M 0.08% 253

Other funds holding REGN